Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

被引:0
|
作者
Yadav, S. [1 ]
Xie, H. [1 ]
Riaz, I. B. [1 ]
Sharma, P. [2 ]
Mahipal, A. [1 ]
McWilliams, R. [1 ]
机构
[1] Mayo Clin, Dept Oncol, Rochester, MN USA
[2] Yale New Haven Hlth Syst, Bridgeport Hosp, Dept Internal Med, Bridgeport, CT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
763P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
    Yadav, Siddhartha
    Xie, Hao
    Bin-Riaz, Irbaz
    Sharma, Prabin
    Durani, Urshila
    Goyal, Gaurav
    Borah, Bijan
    Borad, Mitesh J.
    Smoot, Rory L.
    Roberts, Lewis R.
    Go, Ronald S.
    McWilliams, Robert R.
    Mahipal, Amit
    EJSO, 2019, 45 (08): : 1432 - 1438
  • [2] PROPENSITY SCORE-MATCHED ANALYSIS OF NEOADJUVANT VS. ADJUVANT THERAPY IN RENAL CELL CARCINOMA
    Cesare, Saitta
    Mimi, V. Nguyen
    Giacomo, Musso
    Kevin, Hakimi
    Dattatraya, Patil
    Hajime, Tanaka
    Luke, Wang
    Margaret, F. Meagher
    Dhruv, Puri
    Kit, Yuen
    Masaki, Kobayashi
    Shohei, Fukuda
    Giuseppe, Garofano
    Giovanni, Lughezzani
    Nicolo, Buffi
    Viraj, Master
    Ithaar, H. Derweesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [3] Adjuvant Chemotherapy Surgical Resection in Cholangiocarcinoma: A Propensity Score Matched Cohort Study
    Kamarajah, Sivesh Kathir
    Bhogal, Ricky
    Coldham, Chris
    Weston, Chris
    Mirza, Darius
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 24 - 25
  • [4] Neoadjuvant vs Adjuvant Chemotherapy in Resected Ampullary Carcinoma: A Propensity-Matched Cohort Analysis
    Kerekes, Daniel M.
    Frey, Alexander E.
    Becher, Robert D.
    Khan, Sajid A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S248 - S249
  • [5] NEOADJUVANT VS ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY MATCHED ANALYSIS
    Jue, Joshua
    Koru-Sengul, Tulay
    Miao, Feng
    Velasquez, Maria
    Savio, Luis
    Alameddine, Mahmoud
    Kroeger, Zachary
    Ritch, Chad
    Gonzalgo, Mark
    JOURNAL OF UROLOGY, 2018, 199 (04): : E313 - E313
  • [6] Neoadjuvant chemotherapy vs primary debulking surgery: A propensity score matched cohort analysis of survival
    Barber, E. L.
    Van Le, L.
    Dusetzina, S. B.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 68 - 68
  • [7] Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data
    Watanuki, Rurina
    Hayashida, Tetsu
    Yokoe, Takamichi
    Kawai, Yuko
    Kikuchi, Masayuki
    Nakashoji, Ayako
    Nagayama, Aiko
    Seki, Tomoko
    Takahashi, Maiko
    Kitagawa, Yuko
    BREAST JOURNAL, 2020, 26 (09): : 1765 - 1770
  • [8] Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
    Li, Qing
    Chang, Zhenyu
    Wang, Tianyi
    Liu, Bing
    Wang, Ximin
    Ge, Xin-Yu
    Yang, Tao
    Liu, Qu
    Wang, Wei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Adjuvant chemotherapy for node-negative gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy: A propensity score matched analysis study
    Wong, Enoch
    Kamarajah, Sivesh K.
    Dahdaleh, Fadi
    Naffouje, Samer
    Kunene, Victoria
    Fackrell, David
    Griffiths, Ewen A.
    EJSO, 2025, 51 (03):
  • [10] Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
    Labrosse, Julie
    Osdoit, Marie
    Hamy, Anne-Sophie
    Coussy, Florence
    Pierga, Jean-Yves
    Reyal, Fabien
    Laas, Enora
    PLOS ONE, 2020, 15 (06):